The Opportunity
…If you went to your primary care physician for a medical procedure and were informed: “the doctor only uses treatment methods from 25 years ago,” would you tolerate it? Unfortunately, this is too often the case when people seek out therapy for depression, anxiety, and stress…with no other options. Plus, most people are uninformed about the options that could be…This has to change
Atheneum Learning™ is uniquely positioned to combine the best content in behavioral health with innovative e-learning solutions for two major markets: professionals who provide treatment, and consumers in the general public who desperately need effective and trustworthy content. We start with top-tier content from world-class subject matter experts—SMEs—all part of Dr. Neuhaus’ close network at Harvard Medical School, Yale, and other leading institutions. We then design e-learning products that adapt the content for specific market needs. Professional clinicians (e.g., psychologists, psychiatrists, social workers, nurses) gain access to training in the most effective treatment approaches with continuing education (CE) credits certified through McLean Hospital/Harvard Medical School. Consumers gain closer access to trusted SMEs who provide education, guidance, and inspiration.
The Pain: In the United States alone, over 100 million people suffer from psychiatric and stress related problems, with a substantial impact on families and the workplace. To put this in perspective, depression is the leading cause of absences at work.
Over 25 million people are prescribed anti-depressant medication for depression and anxiety disorders, a $10 billion industry for “big pharma” with only mediocre results. The best outcomes are seen with psychological and behavioral treatments—evidence-based treatments developed and tested through research, that are either an alternative to meds, or greatly enhance treatment response. Evidence-based treatments are the new standard of care. A significant problem exists, however, as not enough professionals or consumers have access to these most effective treatments and resources.